EKF Diagnostics Holdings plc EKF
The next EKF Diagnostics Holdings plc dividend is expected to go ex in 5 months and to be paid in 6 months.
The previous EKF Diagnostics Holdings plc dividend was 1.1p and it went ex 7 months ago and it was paid 6 months ago.
There is typically 1 dividend per year (excluding specials), and the dividend cover is approximately 2.0.
|Summary||Previous dividend||Next dividend|
|Per share||1.1p||Sign Up Required|
|Declaration date||30 Mar 2021 (Tue)||–|
|Ex-div date||04 Nov 2021 (Thu)||03 Nov 2022 (Thu)|
|Pay date||01 Dec 2021 (Wed)||01 Dec 2022 (Thu)|
Enter the number of EKF Diagnostics Holdings plc shares you hold and we'll calculate your dividend payments:
Sign up for EKF Diagnostics Holdings plc and we'll email you the dividend information when they declare.
Add EKF Diagnostics Holdings plc to receive free notifications when they declare their dividends.
Your account is set up to receive EKF Diagnostics Holdings plc notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Final||–||31 Oct 2024||28 Nov 2024||GBP||Sign up||—|
|Forecast||Final||–||02 Nov 2023||30 Nov 2023||GBP||Sign up||—|
|Forecast||Final||–||03 Nov 2022||01 Dec 2022||GBP||Sign up||—|
|Paid||Final||30 Mar 2021||04 Nov 2021||01 Dec 2021||GBP||—||1.1p|
|Paid||Final||15 Jul 2019||05 Nov 2020||01 Dec 2020||GBP||—||1p|
EKF Diagnostics Holdings plc Optimized Dividend Chart
About EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
- Health Care Equipment & Services
- United Kingdom
- Share Price
- £0.35 (yesterday's closing price)
- Shares in Issue
- 464 million
- Market Cap
- Market Indices